Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Preventability of invasive pneumococcal disease and assessment of current polysaccharide vaccine recommendations for adults: United States, 2001-2003.
Greene CM, Kyaw MH, Ray SM, Schaffner W, Lynfield R, Barrett NL, Long C, Gershman K, Pilishvili T, Roberson A, Zell ER, Whitney CG, Bennett NM; Active Bacterial Core Surveillance Program of the Emerging Infections Program Network. Greene CM, et al. Among authors: gershman k. Clin Infect Dis. 2006 Jul 15;43(2):141-50. doi: 10.1086/505117. Epub 2006 Jun 9. Clin Infect Dis. 2006. PMID: 16779739
Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005.
Moore MR, Gertz RE Jr, Woodbury RL, Barkocy-Gallagher GA, Schaffner W, Lexau C, Gershman K, Reingold A, Farley M, Harrison LH, Hadler JL, Bennett NM, Thomas AR, McGee L, Pilishvili T, Brueggemann AB, Whitney CG, Jorgensen JH, Beall B. Moore MR, et al. Among authors: gershman k. J Infect Dis. 2008 Apr 1;197(7):1016-27. doi: 10.1086/528996. J Infect Dis. 2008. PMID: 18419539
Prevention of antibiotic-nonsusceptible Streptococcus pneumoniae with conjugate vaccines.
Hampton LM, Farley MM, Schaffner W, Thomas A, Reingold A, Harrison LH, Lynfield R, Bennett NM, Petit S, Gershman K, Baumbach J, Beall B, Jorgensen J, Glennen A, Zell ER, Moore M. Hampton LM, et al. Among authors: gershman k. J Infect Dis. 2012 Feb 1;205(3):401-11. doi: 10.1093/infdis/jir755. Epub 2011 Dec 7. J Infect Dis. 2012. PMID: 22158567
An assessment of the screening method to evaluate vaccine effectiveness: the case of 7-valent pneumococcal conjugate vaccine in the United States.
Cohen AL, Taylor T Jr, Farley MM, Schaffner W, Lesher LJ, Gershman KA, Bennett NM, Reingold A, Thomas A, Baumbach J, Harrison LH, Petit S, Beall B, Zell E, Moore M. Cohen AL, et al. PLoS One. 2012;7(8):e41785. doi: 10.1371/journal.pone.0041785. Epub 2012 Aug 1. PLoS One. 2012. PMID: 22870248 Free PMC article.
Reduced influenza antiviral treatment among children and adults hospitalized with laboratory-confirmed influenza infection in the year after the 2009 pandemic.
Garg S, Chaves SS, Pérez A, D'Mello T, Gershman K, Meek J, Yousey-Hindes K, Arnold KE, Farley MM, Tengelsen L, Ryan P, Sharangpani R, Lynfield R, Morin C, Baumbach J, Hancock EB, Zansky S, Bennett NM, Fowler B, Bradley K, Thomas A, Cooper T, Schaffner W, Boulton R, Finelli L, Fry AM. Garg S, et al. Among authors: gershman k. Clin Infect Dis. 2012 Aug;55(3):e18-21. doi: 10.1093/cid/cis442. Epub 2012 Apr 27. Clin Infect Dis. 2012. PMID: 22543024
Effect of the 2009 influenza A(H1N1) pandemic on invasive pneumococcal pneumonia.
Fleming-Dutra KE, Taylor T, Link-Gelles R, Garg S, Jhung MA, Finelli L, Jain S, Shay D, Chaves SS, Baumbach J, Hancock EB, Beall B, Bennett N, Zansky S, Petit S, Yousey-Hindes K, Farley MM, Gershman K, Harrison LH, Ryan P, Lexau C, Lynfield R, Reingold A, Schaffner W, Thomas A, Moore MR. Fleming-Dutra KE, et al. Among authors: gershman k. J Infect Dis. 2013 Apr;207(7):1135-43. doi: 10.1093/infdis/jit008. Epub 2013 Jan 9. J Infect Dis. 2013. PMID: 23303809
Adults with invasive pneumococcal disease: missed opportunities for vaccination.
Kyaw MH, Greene CM, Schaffner W, Ray SM, Shapiro M, Barrett NL, Gershman K, Craig AS, Roberson A, Zell ER, Schuchat A, Bennett NM, Whitney CG; Active Bacterial Core Surveillance Program of the Emerging Infections Program Network. Kyaw MH, et al. Among authors: gershman k. Am J Prev Med. 2006 Oct;31(4):286-92. doi: 10.1016/j.amepre.2006.06.007. Epub 2006 Aug 22. Am J Prev Med. 2006. PMID: 16979452
The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004.
O'Loughlin RE, Roberson A, Cieslak PR, Lynfield R, Gershman K, Craig A, Albanese BA, Farley MM, Barrett NL, Spina NL, Beall B, Harrison LH, Reingold A, Van Beneden C; Active Bacterial Core Surveillance Team. O'Loughlin RE, et al. Among authors: gershman k. Clin Infect Dis. 2007 Oct 1;45(7):853-62. doi: 10.1086/521264. Epub 2007 Aug 29. Clin Infect Dis. 2007. PMID: 17806049
77 results